SEC Tracker
Get the app

Valion Bio VBIO

Valion Bio reports Lisa Wolf's resignation

Item 5.02 Executive or director change

Form
8-K
Filed
Importance
Major
  1. Lisa Wolf resigns as President, COO, and CFO
  2. Resignation effective December 11, 2026
  3. Dean Zikria is Interim CEO

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Valion Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Healthy Extracts HYEX public float $4M, Jun 30, 2025
  2. Theriva Biologics TOVX public float $4M, Jun 30, 2025
  3. Jaguar Health JAGX public float $4M, Jun 30, 2025
  4. China Pharma Holdings CPHI public float $4M, Jun 30, 2025
  5. Synlogic SYBX public float $4M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.